Is Coca-Cola Amatil Ltd ready to win in Indonesia in 2015?

The Coca-Cola Company's $US500 million investment in Coca-Cola Amatil Ltd's (ASX:CCL) Indonesian business has been approved by its board, is it now time to buy?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a tough year shareholders in Coca-Cola bottler and distributor Coca-Cola Amatil Ltd (ASX: CCL).

With earnings per share falling and its share price down 26% for the year, shareholders have felt the pain of intense competition with rival bottler Schweppes, as well as an ongoing price war between supermarket giants Coles and Woolworths.

Whilst the Australian business accounts for over 58% of CCA's revenues, it's in Indonesia where shareholders are hoping the company can generate sustainable long-term growth.

Unfortunately in Indonesia things haven't played out as planned and CCA hasn't achieved the success it wants. In FY13 the Indonesian business achieved strong sales despite revenue per unit case reducing by 2%. However significant wage and cost inflation have taken their toll on earnings.

Is this a turnaround in the making?

In the wake of CEO Alison Watkins' operational review, which included running the scalpel across the entire group, CCA's parent and substantial shareholder, The Coca-Cola Company, has decided to inject $US500 million for a 29.4% equity stake in the Indonesian business.

The new capital will help strengthen its market leadership position and enable the company to ramp up its capital expenditure to approximately $150 million per annum over the next three to four years. Infrastructure expansion and a broadening of its product offering (including a greater range of affordable packages) are the proposed uses. It'll be able to self-fund growth until 2020.

Today CCA announced to the ASX that The Coca-Cola Company has received applicable board approvals to proceed with its investment. Despite the requirement for Indonesian regulatory approvals and CCA non-associated shareholder approval, it seems investors can finally be optimistic about the group's future in Asia.

Buy, Hold, or Sell?

If CCA can deliver on its $100 million savings target and its new marketing campaign in Australia and in Indonesia, its stock will look very cheap at today's prices. Indeed with a prominent brand and the backing of one of the world's best companies, it could be worthy of further consideration in 2015.

Motley Fool Contributor Owen Raszkiewicz is long June 2016 $5.41 warrants in Coca-Cola Amatil. You can follow Owen on Twitter @ASXinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »